Part of Thermo Fisher Scientific

Hepatitis B Virus Surface Antigen Polyclonal Antibody

Hepatitis B Virus Surface Antigen Antibody for ELISA, IDF, IE, Western blot

Synonyms:
HepB, HBsAg
Entrez Gene ID:
(Virus) 944568
UniProt ID:
Q784Z8
Details
Host / Isotype: Duck / IgY
Class: Polyclonal
Type: Antibody
Species Reactivity: Virus (Vs)
Immunogen: Recombinant Hepatitis B surface antigen (HbsAg), subtype adr
Ordering Information
Pierce Hepatitis B Virus Surface Antigen Polyclonal Antibody
Product Number Pkg. Size Price Purchase
D1901-2B 2 mg $273.00
Add Hepatitis B Virus Surface Antigen Polyclonal Antibody to your cart.

This product is not available outside of the U.S.

Storage: -20ยบ C, Avoid Freeze/Thaw Cycles, store in dark
Form: 2 mg of purified IgY (deltaFc) in 20 mM MES (2-(N-morpholino) ethanesulfonic acid, pH 5.8) containing 0.1% sodium azide.


Applications Dilution *
Immunodiffusion (IDF) Assay dependent
Western Blot (WB) Assay dependent
ELISA (ELISA) Assay dependent
Immunoelectrophoresis (IE) Assay dependent
* Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Product Specific Information
D1901-2B detects Hepatitis B Virus Surface Antigen from infected samples.

D1901-2B has been successfully used in ELISA, immunodiffusion, immmunoelectrophoresis and Western blot applications.

The D1901-2B immunogen is recombinant Hepatitis B surface antigen (HbsAg), subtype adr.
General Information
The hepatitis B virus is an important cause of acute and chronic liver disease. It is also the most common form of parenterally transmitted viral hepatitis. The virus is estimated to affect some 350 million people worldwide. Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries. Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus. In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas. There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.
(This product is for In Vitro experimental use only. Not for resale without express authorization.)